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Abstract Wheat germ cell-free methods provide an
important approach for the production of eukaryotic pro-
teins. We have developed a protein expression vector for
the TNT
 SP6 High-Yield Wheat Germ Cell-Free (TNT
WGCF) expression system (Promega) that is also com-
patible with our T7-based Escherichia coli intracellular
expression vector pET15_NESG. This allows cloning of
the same PCR product into either one of several
pET_NESG vectors and this modiﬁed WGCF vector
(pWGHisAmp) by In-Fusion LIC cloning (Zhu et al. in
Biotechniques 43:354–359, 2007). Integration of these two
vector systems allowed us to explore the efﬁcacy of the
TNT WGCF system by comparing the expression and
solubility characteristics of 59 human protein constructs in
both WGCF and pET15_NESG E. coli intracellular
expression. While only 30% of these human proteins could
be produced in soluble form using the pET15_NESG based
system, some 70% could be produced in soluble form using
the TNT WGCF system. This high success rate underscores
the importance of eukaryotic expression host systems like
the TNT WGCF system for eukaryotic protein production
in a structural genomics sample production pipeline. To
further demonstrate the value of this WGCF system in
producing protein suitable for structural studies, we scaled
up, puriﬁed, and analyzed by 2D NMR two
15N-,
13C-
enriched human proteins. The results of this study indicate
that the TNT WGCF system is a successful salvage path-
way for producing samples of difﬁcult-to-express small
human proteins for NMR studies, providing an important
complementary pathway for eukaryotic sample production
in the NESG NMR structure production pipeline.
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Introduction
Cell-free expression systems are capable of generating
small quantities of soluble eukaryotic proteins in instances
where traditional bacterial expression systems have failed
[7, 17]. Cell-free systems can also accommodate a variety
of isotopic enrichment schemes and are capable of
routinely generating labeled protein in quantities sufﬁcient
for structural analysis by solution NMR [12, 13]. The
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DOI 10.1007/s10969-010-9093-8Northeast Structural Genomics Consortium (NESG,
www.nesg.org), a large-scale center funded by the National
Institutes of General Medical Sciences (NIGMS), has to
date created some 5,000 eukaryotic protein expression
plasmids, mostly using modiﬁed pET vectors [pET_NESG
vectors [1]] for cell-based production in E. coli. Although
our success over the past 5 years in producing a speciﬁc
protein is greatly enhanced by cloning multiple constructs
of the same target, even using this strategy success rates in
producing a soluble construct for a speciﬁc eukaryotic
protein in our E. coli based expression system (26%) is
signiﬁcantly lower than the corresponding success rates for
targets of prokaryotic origin (42%) (statistics posted at
www.nesg.org). Within the NIGMS Protein Structure Ini-
tiative, the Center for Eukaryotic Structural Genomics
(CESG) has pioneered the use of wheat germ cell-free
systems for producing eukaryotic proteins for a wide range
of applications (see for example [17, 18]). The wheat germ
cell-free system is particularly advantageous for preparing
samples for NMR studies, as it is relatively inexpensive to
incorporate
15N and
13C isotopes when compared with
other eukaryotic expression hosts. Here we describe pro-
gress in developing a cell-free protein expression pipeline
that parallels the NESG HTP pET-based E. coli expression
pipeline [1], allowing routine use of WGCF systems for
salvage of certain eukaryotic proteins.
There are three widely utilized cell-free systems each
based on cellular extracts [7]. These are derived from either
E. coli, rabbit reticulocytes, or wheat germ. Such extracts
contain all of the macromolecular machinery required for
translation, such as ribosomes, elongation and termination
factors, tRNAs, etc. E. coli cell-free expression systems
have been used successfully in structural genomics [2, 4];
indeed the Riken Structural Genomics/Proteomics Initia-
tive (RSGI) protein production pipeline is based on this
type of cell-free translation. Unfortunately eukaryotic
proteins often possess multiple domains, which tend to
missfold in prokaryotic (e.g., E. coli) expression systems
[16]. The rabbit reticulocyte system tends to have low
efﬁciency, and hence not cost effective for producing the
quantities of protein necessary for protein structure deter-
mination [7]. Wheat germ extracts, however, have been
demonstrated to be well-suited for isotopic enrichment, and
for cost-effective production of hundred microgram quan-
tities of proteins sufﬁcient for NMR studies [12, 13, 15, 17,
18].
With support from the Protein Structure Initiative of the
NIGMS, the NESG has successfully constructed a protein
structure production pipeline centered on an automated
HTP multiplexed cloning platform [1]. The platform is
fully integrated with a laboratory information management
system and PCR primer/construct design tools [8]. To take
full advantage of the NESG protein production
infrastructure, we require a modiﬁed wheat germ cell-free
(WGCF) vector that is compatible with the current cloning
and expression procedures. In particular, we require a
system that is compatible with the same PCR products used
in our modiﬁed pET_NESG vectors (described in Acton
et al. [1]).
Here we describe modiﬁcations to the Promega TNT

SP6 High-Yield Wheat Germ Cell-Free (TNT WGCF)
expression system that allow utilization of the same PCR
products generated for the NESG HTP pET-based cloning
platform. Utilization of the TNT WGCF system avoids the
cumbersome handling of mRNA, by coupling the processes
of transcription and translation in one optimized extract
[20]. This is achieved by the addition of SP6 RNA poly-
merase to the WGCF reaction and the inclusion of an SP6
promoter to the template DNA. Other commercially
available systems require the separate generation of mRNA
template. This ﬁnite mRNA supply is then added to the
WGCF protein translation reaction. By contrast, the Pro-
mega TNT
 requires only the addition of DNA template
for protein expression.
Promega provides a number of vectors that are com-
patible with the TNT WGCF system. In order to make the
cloning and protein puriﬁcation compatible with the cur-
rent NESG platform, the pTSHQn vector (based on the
Promega Riboprobe
 System Vector pSP64) was subjected
to several modiﬁcations. We describe the new vector,
pWGHisAmp and demonstrate its use with the TNT
WGCF system in obtaining good expression and solubility
for eukaryotic protein targets. Using the NESG protein
production platform, a set of 59 human protein constructs
were then cloned and expressed in the TNT WGCF system
and, in parallel, in our intracellular pET15_NESG E. coli
system. To gauge the feasibility of using such samples for
protein NMR structure applications, two of these human
proteins were also isotope enriched and subsequently
analyzed by 2D NMR using a micro cryo NMR probe. The
TNT WGCF approach represents a viable salvage pathway
of the NESG structure production pipeline for eukaryotic
protein targets exhibiting poor expression and/or solubility
in intracellular E. coli host systems.
Materials and methods
Creation of a WGCF expression vector compatible
with NESG HTP cloning pipeline
The pTSHQn (Kan
R) vector (Promega) was modiﬁed to
allow cloning of the same PCR product into the modiﬁed
WGCF expression vector or our pET15_NESG vector for
T7-based E. coli intracelluar expression. pET15_NESG
produces proteins with a short N-terminal non-cleavable
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123hexaHis tag (MGHHHHHHSH). The backbone of pTSHQn
was PCR ampliﬁed with the primers WG-F (50-GTGATGG
TGATGGCCCATGGCGAATTCTCCTTATTCTATAG-30)
and WG-R (50-GAGATCCGGCTGCTAAGGATCCTCTA
GAGTCGACCTGC-30). Following PCR, the reaction
mixture was treated with DpnI to destroy the pTSHQn
template and subjected to agarose gel electrophoresis. The
ampliﬁed backbone of pTSHQn was excised from the gel
and puriﬁed. The pET15_NESG linker, including the
coding region for a hexaHis-tag, was ampliﬁed by PCR
from the NESG-modiﬁed pET15_NESG plasmid [1] with
the primers pET15_NESG linkerF (50-ATGGGCCATCAC
CATCACCA-30) and pET15_NESG linkerR (50-TTAGC
AGCCGGATCTCGAG-30). The ampliﬁed pET15_NESG
linker was also gel puriﬁed and was then subcloned into the
ampliﬁed pTSHQn backbone by the In-Fusion
TM (Takara)
ligation independent cloning method [21]. Transformation
into E. coli XL-10 gold cells (Stratagene) was followed by
selection on LB/Kan medium. The resulting recombinant
clones were screened by PCR, and a correct clone, desig-
nated pWGHisKan, was validated by DNA sequencing.
To replace the kanamycin resistance gene of pWGHis-
Kan with an ampicillin resistance gene, required for further
standardization with the NESG cloning pipeline, pWGHis-
Kan was PCR ampliﬁed excluding the kanamycin resistance
gene using the primers WGHisF (50-AACCATTACGTA
GAAAGCCAGTCCGCAG-30) and WGHisR (50-TTGGTA
ATTCGAAATGACCGACCAAGCG-30). The ampicillin
resistance gene from pET15_NESG was also ampliﬁed uti-
lizing the primers Amp-F (50-TTCTACGTAATGGTTT
CTTAGACGTCAGG-30)a n dA m p - R( 5 0-ATTTCGAAT
TACCAATGCTTAATCAGTGAG-30). The two PCR
products were gel puriﬁed, subjected to In-Fusion
TM LIC,
transformed into XL-10 gold cells, and selected on LB/Amp
medium. Finally, the resulting pET-compatible WGCF
expression plasmid, designated pWGHisAmp, was
sequenced veriﬁed. The resulting expression vector provides
proteins with an N-terminal non-cleavable hexaHis tag
(MGHHHHHHSH), identical to the N-terminal tag provided
by the pET15_NESG expression vector.
Cloning of target genes
The NESG has constructed a Human Cancer Pathway
Interaction Network (HCPIN), providing structure–function
annotations of key proteins associated with human cancer
and developmental biology [9]. The long-range goal of the
HCPIN project is to provide a comprehensive 3D structure–
function database for human-cancer-associated proteins and
protein complexes in the context of functional networks,
using both experimental structures and high quality homol-
ogy models (i.e., using protein templates with [80%
sequence identity). Coding regions for 59 human protein
targets or domains selected mostly from the HCPIN target
list were cloned into both the pWGHisAmp vector for
WGCF expression, and into the pET15_NESG vector for E.
coli intracellular expression. Primer sequences were gener-
atedautomaticallyusingthePrimer,Primerprogram[8].The
F-primers are 50-ACCATCACAGCCAT plus gene speciﬁc
sequences and the R-primers are 50-GCAGCCGGATCTC-
GAGCTA plus gene speciﬁc sequences. PCR products were
cloned into NdeI and XhoI digested pWGHisAmp vector by
In-Fusion
TM LIC and transformed into XL-10 gold cells.
Positive clones were screened ﬁrst by colony PCR and then
conﬁrmed by DNA sequencing. The naming convention for
NESG target protein id’s is described elsewhere [19]; the
correspondingproteinsequencesareavailableontheHCPIN
web site (http://nesg.org:9090/HCPIN/index.jsp).
T7-based E. coli intracellular protein expression
pET15_NESG plasmids were transformed into
BL21(DE3)pMgK cells and expression analysis performed
following standard NESG pipeline methods, as described
elsewhere [1].
Expression screening a WGCF small-scale batch
reaction with FluoroTect
TM detection
Cell-free protein synthesis screening was performed using
TNT SP6 High-Yield WGCF (Promega) and Fluoro-
Tect
TM (Promega) in vitro ﬂuorophore labeling of target
proteins. DNA was puriﬁed using Qiaprep 96 Turbo
(Qiagen). For each reaction, 14 lL of TNT WGCF lysate
(Promega) was mixed with 2 lg of plasmids, 0.5 lLo f
FluoroTect
TM (Promega), and nuclease-free H2O to a ﬁnal
volume of 20 lL. These batch reactions were incubated in
microfuge tubes at room temperature for 2 h followed by
addition of 1 lL of RNase A (Qiagen) to each reaction, and
incubated at 37 C for 10 min to hydrolyze unincorporated
ﬂuorophore-labeled tRNA. Total protein solubility was
determined by SDS PAGE analysis of 1 lL of the total
reaction compared with the 1 lL of the soluble protein
supernatantresultingfromcentrifugationat3,0009gat4 C
for 10 min. Detection of FluoroTect
TM labeled proteins was
accomplished directly by scanning the gels with a laser-
based ﬂuorescent gel scanner (Typhoon 8600, GE Health-
care), with excitation of 488 nm and emission of 532 nm.
Protein production scale-up using WGCF dialysis
reaction
Select targets identiﬁed as well-expressed and soluble in
the HTP FluoroTect screen were subsequently scaled up
using a dialysis process. For each 100 ll small-scale
Engineering of a wheat germ expression system 203
123dialysis reaction, 60 lL of wheat germ lysate (TNT
WGCF) was mixed with 20 lg of expression plasmid
puriﬁed using a Nucleobond Xtra Maxi Plus kit (Mache-
rey–Nagel GmbH & Co. KG). Nuclease-free H2O was
added to obtain the ﬁnal reaction volume. The reactions
were set up in microfuge tubes, transferred into GeBaFlex-
tube mini dialysis cups (Gen Bio-Applications Ltd), and
inserted into a 2 mL microfuge tube containing 1 mL of
dialysis buffer. Dialysis buffer [20] consists of 12 mM
HEPES, pH 7.6, 0.5 mM spermidine, 5 mM DTT, 80 lM
amino acids, 100 mM KOAc, 1.2 mM ATP, 0.1 mM GTP,
10 mM CP, and 1.5 mM Mg(OAc)2. Reactions were
incubated at room temperature for 24 h and then at 4 C for
1–2 days before protein expression analysis.
Isotope enrichment
For isotope enrichment, 2–3 mL dialysis reactions were
carried out using amino-acid-depleted WGCF lysate and
15N-,
13C enriched amino acids. In these reactions, 1.2–
1.8 mL of TNT WGCF lysate minus amino acids (not yet
commercially available) was mixed with 400–600 lgo f
puriﬁed plasmid [prepared using a Nucleobond Xtra Maxi
Plus kit (Macherey–Nagel GmbH & Co. KG], and 1 mM
(or 100 lM)
15N-,
13C-enriched amino acids (Cambridge
Isotopes Laboratories). Nuclease-free H2O was added to
make up the ﬁnal reaction volume.
15N-,
13C-enriched





13C-enriched human ubiquitin was prepared in a 2 mL
dialysis reaction containing 1 mM
15N-,
13C-labeled amino
acids. The reactions were incubated in 3 mL Slide-A-Lyzer
dialysis cassettes (Pierce) against 100 mL dialysis buffer
containing
15N-,
13C-labeled amino acids (same concentra-
tion) at room temperature with gentle stirring for 24 h, and
then transferred to 4 C for 1–2 days before protein
expression analysis.
Protein puriﬁcation
To quantitate protein synthesis in the 100 lL dialysis
reaction, puriﬁcation was performed using MagneHis
(Promega) magnetic beads. The reaction mixture was
transferred to a 1.5 mL microfuge tube and mixed with
350 lL of Binding Buffer A (50 mM HEPES, pH 7.5,
500 lM NaCl and 20 mM imidazole), followed by centri-
fugation (10,0009g for 10 min). The supernatant was col-
lected, and 150 lL was then transferred to a new microfuge
tube containing 30 lL of magnetic beads. Following mix-
ing and incubation at room temperature, the magnetic beads
were isolated using a 96-Well Magnet Type A (Qiagen), the
remaining solution was discarded. Using the same beads
this process was repeated for additional 150 lL aliquots of
supernatant. The beads were washed three times with
150 lL of binding buffer using the 96-Well Magnet Type A
to capture the magnetic beads. Bound proteins were eluted
in 50 lL of Elution Buffer (50 mM Tris, pH 7.5, 500 mM
NaCl, 500 mM imidazole) and the results visualized by
SDS–PAGE analysis.
Mini columns with 0.5–1 mL of Ni–NTA resin (Qiagen)
were used to purify the
15N-,
13C-enriched proteins, syn-
thesized with larger scale dialysis reactions. Brieﬂy, 5
volumes of Binding Buffer B (50 mM Tris, pH 7.5,
500 mM NaCl, 40 mM imidazole) were added to the
reaction mixtures, followed by centrifugation at 10,0009g
for 10 min. The supernatant was loaded onto a Ni–NTA
column and washed with 10 volumes of Binding Buffer.
The bound proteins were eluted with Elution Buffer and
analyzed by SDS PAGE.
Buffer exchange and sample concentration
Target-protein containing fractions were pooled and
exchanged into 19 NMR Buffer (20 mM MES, pH 6.5,
200 mM NaCl, 10 mM DTT and 19 Roche Protease
Inhibitor Cocktail). In brief, 19 NMR Buffer was added to
the eluate (4 mL ﬁnal volume), mixed and transferred to a
4 mL Amicon Ultra centrifugal ﬁlter device (5 kDa
MWCO). This was subsequently followed by centrifuga-
tion at 3,0009g at 4C for 40 min. The ﬂow through was
discarded and 19 NMR Buffer was added to the sample to
4 mL and again centrifuged at 3,0009g at 4C for 50 min.
Remaining sample (about 150 lL) was then transferred to
a new 1.5 mL Amicon Ultra centrifugal ﬁlter device
(5 kDa MWCO) and mixed with 300 lLo f1 9 NMR
Buffer and centrifuged at 10,0009g for 40 min at 4 C.
The ﬂow through solution was discarded and 400 lLo f1 9
NMR buffer added to the remaining material (*25 lL).
The sample was again subjected to centrifugation at
10,0009g for 40 min at 4 C. Then another 400 lLo f1 9
NMR Buffer was added and the sample subjected to a
ﬁnal centrifugation as previously described.
2H2O and 2,
2-dimethyl-2-silapentane-5-sulfonic acid (DSS) were added
at 10 and 1%, for locking and referencing, respectively.
Following buffer exchange into 19 NMR Buffer and the
addition of
2H2O and DSS, samples we’re concentrated
down to a volume of about 38 lL for NMR measurements.
Labeling efﬁciency analysis
An aliquot of each puriﬁed
15N-,
13C-enriched protein was
run on a 4–12% NuPage SDS–PAGE gel (Invitrogen).
Target bands (about 1–2 lg) were excised and submitted to
the Biological Mass Spectrometry Facility of the Center for
Advanced Technology and Medicine. In-gel tryptic diges-
tions were performed and analyzed on a 4800 MALDI-
204 L. Zhao et al.
123TOF/TOF Analyzer (Applied Biosystems). Theoretical
average masses, both labeled and unlabeled, were calcu-
lated for several
15N-,
13C-enriched tryptic peptides and
compared to the average masses observed by mass spec-
trometry. Labeling efﬁciency was calculated from the ratio





1H HSQC spectra were aquired for the WGCF-
derived proteins ubiquitin (35 lL, *0.3 mM) and
HR3597B (35 lLa t*0.4 mM) in NMR buffer. In both
cases, the NMR data was collected using the following
typical parameters: 64 scans with 64 t1 (
15N-dimension)
increments and 2048 t2 (
1H-dimension) increments using a
1 s recycle delay. Total data collection time in each case
was 2 h and 40 min. Data were collected at a temperature
of 25 C using a Bruker 600 MHz spectrometer ﬁtted with
a 1.7 mM micro-cryoprobe. Chemical shifts were refer-
enced to internal DSS.
Results
Vector engineering
To date the NESG has created some 5,000 pET-based
expression constructs for eukaryotic protein, including
expression vectors for 2,963 constructs corresponding to
1,743 human proteins (statistics available on line at
www.nesg.org). These E. coli intracellular expression
constructs consist of domains and full-length proteins
cloned into one of three NESG-modiﬁed pET vectors [1].
In 2006, the NESG adopted the In-Fusion
TM (Takara)
Ligation Independent Cloning (LIC) method to meet most
of its cloning needs. Brieﬂy, LIC cloning, by strand dis-
placement and resection by the InFusion enzyme [14],
requires that the target PCR product share 15 nucleotides
complimentary to the site of vector linearization.
The WGCF expression vector pTSHQn from Promega,
contains an N-terminal metal-afﬁnity puriﬁcation tag
sequence MASSHQHQHQHQHQAIA (HQ tag) and a
kanamycin (kan
r) resistance gene for selection. This afﬁnity
tag andselection agentdifferfromthosecurrently employed
bytheNESG.ThepTSHQnvectorwasaccordinglymodiﬁed
to make it more compatible with the existing protein pro-
duction platform and PCR products. First, pWGHisKan was
created by replacing the N-terminal HQ tag and ORF of
pTSHQn with a pET15_NESG linker sequence and
MGHHHHHHSH non-cleavable hexaHis tag. This change
allows the same PCR product to be cloned into both the
pET15_NESG vector for bacterial intracellular expression
or into pWGHisKan for cell-free expression. Secondly, the
kanamycin resistance gene of pWGHisKan was replaced
with an ampicillin resistance gene to generate a new fully
compatible vector called pWGHisAmp. These changes are
depicted graphically in Fig. 1. Proteins produced by either
intracellular bacterial expression or WGCF will have the
same protein sequence and afﬁnity tag, thereby allowing for
parallel cloning and expression screening. However, pro-
teins produced with the WGCF system may exhibit advan-
tageous differences in folding and aggregation properties.
Screening of human protein expression
with the modiﬁed WGCF system and comparison
with in-cell expression in E. coli
Asetof58non-structuredproteintargets(seesupplementary
data)wereselectedfromtheHumanCancerPathwayProtein
Interaction Network (HCPIN) [9], along with full length
human ubiquitin (sp id: P62988). These targets were cloned
into our pET15_NESG and pWGHisAmp vectors. Expres-
sion and solubility in the pET15_NESG system was assayed
following transformation into BL21(DE3)pMgK E.coli
cells. Expression was ranked on a relative scale from 0 to 5,
where 5 indicates the highest levels of expression observed
for that system. The degree to which the total protein
expressed remained soluble following lysate centrifugation
was also represented on a relative scale of 0–5, where 5 is
indicates [90% of the expressed protein is in the soluble
fraction.
Fig. 1 Vector engineering schema illustrating the creation of the
plasmid pWGHisAmp from pTSHQn (Promega), and the NESG
modiﬁed pET15 vector. PCR and In-Fushion
TM ligation independent
cloning methods were used to replace the ORF and HQ metal afﬁnity
tag in pTSHQn with the pET15 linker region and 6xHis metal afﬁnity
tag to generate pWGHisKan. This was subsequently followed by
replacement of the kanamycin resistance gene in pWGHisKan with
the pET15 ampicillin resistance gene to generate the ﬁnal vector
pWGHisAmp. PCR derived products can now be cloned into either
the NESG modiﬁed pET15 bacterial expression plasmid or into the
pWGHisAmp plasmid for wheat germ cell-free expression
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123In this work, we used the FluroTect
TM GreenLys tech-
nology [6, 11] to introduce ﬂuorescent-labeled Lys residues
at certain AAA codon sites, allowing visualization of target
protein even in the presence of high levels of background
proteins from the WGCF system itself. The FluoroTect
TM
GreenLys in vitro Translation Labeling System allows the
ﬂuorescent labeling of translation products through the use
of a modiﬁed charged lysine tRNA labeled with the ﬂuo-
rophore BODIPY-FL. Using this system, ﬂuorescently
labeled lysine residues are incorporated into nascent pro-
teins during translation. The ﬂuorescent lysine is added to
the translation reaction as a charged ﬂuorescent lysine-
tRNA complex (FluoroTect
TMGreenLys tRNA) rather than
a free amino acid. Although only a fraction of the few Lys
residues in each protein molecule are modiﬁed, it cannot be
excluded that the FluoroTect
TM tag affects (negatively or
positively) the observed solubility of the targeted protein.
In addition, the apparent expression level (i.e., ﬂuorescence
intensity) depends on the number of Lys residues that have
been substituted with a e-labeled lysine via the modiﬁed
tRNA, and can only be compared qualitatively with other
methods of protein visualization such as Coomassie Blue
dye binding. Further, the ﬂuorescence detection technology
is also considerably more sensitive than the aforemen-
tioned dye binding. This raises the possibility that solu-
bility may only appear greater as the protein levels detected
are below that favoring aggregation. Despite these impor-
tant caveats, the FluoroTect
TM labeling approach is an
excellent ﬁrst pass screening method for assessing
expression and solubility of proteins produced in the
WGCF system at relatively low levels compared to back-
ground proteins. These targets can then be scaled up
without FluoroTect
TM labeling.
E. coli intracellular protein expression and solubility
levels were scored for each protein on a scale of 0–5 for
expression (E) in the total cell extract; and on a scale of
0–5 for solubility (S) of the expressed protein in the soluble
extract (S) based on Commassie Blue stain binding using
SDS–PAGE. In our hands, proteins with a product E 9 S
(ES score)[12 can be scaled up to produce puriﬁed pro-
teins at levels of[20 mg/L. WGCF expression results were
scored in a similar way, using FluoroTect
TM labeling with
SDS–PAGE gels. These FluoroTect
TM ES scores are not
directly comparable to the ES scores for E. coli intracel-
lular expression. In our experience, WGCF Fluoro-
Tect
TMES scores C8 can be scaled up (as described below)
to provide 50–100 lg yields of protein, sufﬁcient for NMR
analysis using microprobe NMR technologies that have
been described elsewhere [3].
E. coli intracellular expression results were grouped
into three classes: proteins with poor expression (E B 1),
proteins with promising expression (E C 2) but poor
solubility (S B 1), and proteins with both promising
expression (E C 2) and solubility (S C 2). In Table 1,
Poor expression and solubility in the cell-based system
are indicated with a ‘‘-’’ symbol, promising expression
and solubility with a ‘‘?’’ symbol.
An SDS–PAGE gel showing results for some of the 59
WGCF screening reactions is presented in Fig. 2. Overall
40 of the 59 human proteins tested (*70%) were expres-
sed with ES values greater than 8 in the WGCF system
(Table 1). More importantly, of 43 human proteins which
could not be produced in the E. coli intracellular system
(34 with low or no expression and 9 that were expressed
but not soluble), 25 were expressed and soluble with ES
values C8 in the WGCF system (sufﬁcient for NMR
analysis). This corresponds to a salvage rate of *60%
(25/43).
Table 1 Expression and solubility screening results for E. coli
intracellular and Promega TNT WGCF expression
E. coli Total constructs WGCF ES C 8 % salvage (%)
Exp. Sol.
-- 34 19 46
?- 96 6 7
?? 16 15 94
59 40 68
The scoring protocol is explained in the text
Fig. 2 Total expression (A) and solubility (B) characteristic of 14
human targets, expressed in wheat germ small-scale ‘‘batch’’ reac-
tions, with FluoroTect
TM detection and excitation at 532 and 488 nm,
respectively. Expression and solubility characteristics corresponding
to in-cell E. coli expressed protein are indicated above the gel (‘‘-’’
corresponding to poor expression or solubility and ‘‘?’’ indicating
promising expression or solubility). The identities by NESG target ID
of the proteins in the order listed are as follows: HR2951, HR2928,
HR3111, HR2930, HR2934, HR2887, HR2965, HR2924, HR2889,
HR2891, HR3007, HR3057, HR3051 and HR2886 (the corresponding
protein sequences can be accessed on line at http://nmr.cabm.
rutgers.edu:9090/PLIMS/targetSummary.jsf)
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123Scale up using dialysis reaction with isotopic
enrichment
Consistent with recent work from Promega [20], we
observe that the protein yield obtained using the simple
batch reaction used above for screening is lower than what
can be obtained using a dialysis reaction. Several proteins
showing good WGCF expression and solubility in the
screening reactions were selected for scale up using the
dialysis method. Small scale dialysis reactions (usually
100 lL) were performed before scale-up with labeled
amino acids, so as to validate which proteins could be
successfully produced prior to isotopic enrichment. Yield
at this scale is generally not detectable by SDS–PAGE gel
analysis of the whole WGCF reaction mixture without
FluoroTect
TM labeling. Therefore, it is necessary to per-
form IMAC puriﬁcation followed by SDS–PAGE gel
analysis. Several proteins, including some proteins which
failed to be produced by E. coli intracellular expression,
were randomly selected to test on small scale dialysis
reaction. After course puriﬁcation by MagneHis (Pro-
mega), all of the selected target proteins were demonstrated
to be produced with a yield of about 2–6 lg per 100 lL
dialysis reaction (data not shown).
To test whether the proteins produced by the WGCF
system are amenable for structural analysis by NMR, two
human proteins (HR3597B and human ubiquitin) were
produced with larger scale dialysis reactions containing
15N-,
13C-labeled amino acids. HR3597B, a putative zinc-
binding protein, showed very low expression in the E. coli
intracellular expression system.
15N-,
13C-enriched human ubiquitin was produced using
a single 2 mL dialysis reaction containing 1 mM labeled
amino acids; HR3597B was produced using two separate
3 mL dialysis reactions (total 6 mL) with 100 lM labeled
amino acids. Samples were puriﬁed by Ni–NTA IMAC, as
described in ‘‘Methods and materials’’, and buffer
exchanged to 35–40 lL of NMR Buffer. Protein yield and
purity was estimated from the SDS–PAGE data in Fig. 3.
About 1 lL of the
15N-,
13C-enriched ubiquitin NMR
buffer exchanged preparation was run in lane 1 of panel
3A. Exactly 10 lL of the
15N-,
13C-enriched HR3597B Ni–
NTA-puriﬁed sample, and 1 lL of the NMR buffer
exchanged preparation were run in lanes 1 and 2, respec-
tively of panel 3B. Lysozyme standards at various con-
centrations were utilized to estimate protein yield.
Approximately 120 lgo f
15N-,
13C-enriched ubiquitin was
produced from a 2 mL dialysis reaction (60 lg protein/mL
dialysis reaction) and about 200 lgo f
15N-,
13C-enriched
HR3597B from a 6 mL dialysis reaction (30 lg protein/mL
dialysis reaction). Following buffer exchange into NMR
Buffer, ﬁnal concentrations were estimated as 0.3 mM for
ubiquitin and 0.4 mM for HR3597B. HR3597B has an ES
value of 9 in the FluoroTect
TM screening assay, demon-
strating that an ES value of 8 is a reasonable threshold for
determining which targets may be scaled up for subsequent
structural analysis. Contaminating proteins with non-engi-
neered Ni-afﬁnity such as those found at *50 kDa are
from the WGCF lysate itself, and are not isotope-enriched.
Therefore, they are not observed in isotope-ﬁltered 2D
[
1H-
15N]–HSQC and related triple resonance NMR spectra.
Although these proteins do not appear to interfere with
NMR studies we are exploring alternative puriﬁcation
methods (HaloTag, Promega; Strep-TagII, Novagen). We
have found the former method removes the contaminating
bands and that the HSQC spectra of the HaloTag puriﬁed
HR3597B did not differ signiﬁcantly from the Ni–NTA
puriﬁed protein. Although this indicates the contaminating
proteins are innocuous, we are in the process of developing
alternate puriﬁcation strategies to allow for production of
more homogenous WGCF protein samples.
Labeling efﬁciency
MALDI-TOF mass spectroscopy was employed to examine
the masses of four tryptic peptides of
15N-,
13C-enriched
ubiquitin produced in the presence of 0.1 and 1.0 mM
15N-,
13C-labeled amino acids. Using 1.0 mM concentrations of
labeled amino acids in the cell free expression media,
typical labeling efﬁciencies are generally[90% (Table 2).
We observe a 1.3-fold enhancement in labeling efﬁciencies
with the 1.0 mM labeled amino acid supplemented dialysis
mixture relative to the reaction using 0.1 mM concentra-
tion (Table 2). It is not known if the same enhancement in
labeling efﬁciency could be optimized with intermediate
concentrations of labeled amino acids (e.g. 0.5 mM) in the
Fig. 3 SDS–PAGE analysis of puriﬁed double-labeled protein pro-
duced by larger-scale dialysis reaction. Lane M in panels A and B
correspond to Precision Plus Protein Marker (Bio-rad). In panel A,
lane 1 was loaded 1 lL of puriﬁed
15N-,
13C-enriched human
ubiquitin in NMR buffer (40 lL preparative volume). In panel B
lane 1 was loaded 10 lL of Puriﬁed HR3597B in elution buffer
(1,900 lL preparative volume) and in lane 2,1 lL of puriﬁed
HR3597B in NMR buffer (40 lL preparative volume). Lanes 2–5 of
panel A contain 0.5, 1.0, 2.0 and 3.0 lg of lysozyme and Lanes 3–5 of
panel B contain 0.3, 1.0 and 2.0 lg of lysozyme
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123reaction mixture. Future work will be directed at this
question.
2D NMR analysis
The 2D HSQC spectrum collected on
15N-,
13C-enriched
ubiquitin (shown in Fig. 4) is well dispersed, with good
signal-to-noise, and superposes well with the 2D HSQC
spectrum of a
15N-,
13C-enriched ubiquitin sample produced
by conventional in-cell pET vector system (not shown).
The 2D HSQC spectra collected on
15N-,
13C-enriched
HR3597B is also of promising quality, sufﬁcient to dem-
onstrate the value of the WGCF system. Secondary struc-
ture prediction (SSpro, Ver.4.5) [5] identiﬁes regular
secondary structure (helix or beta) for only 35 of 100
amino acids in HR3597B. Also, a consensus of 9 predictors
of disorder, determined with the aid of the NESG Dismeta
server (http://www-nmr.cabm.rutgers.edu/bioinformatics/
disorder/), indicates disorder for *30 amino acids, and
suggests that this protein may require Zn as a structural co-
factor. Accordingly, we judge the spectral quality to be
sufﬁcient to demonstrate the feasibility of isotope-enrich-
ment using the TNT WGCF expression system.
Discussion
WGCF provides an important approach for producing
eukaryotic proteins, and is especially valuable for pro-
ducing hundred microgram quantities of isotope-enriched
protein samples for NMR studies [12, 13, 15, 18]. We have
previously demonstrated that good quality 3D structures of
small (\10 kDa) proteins can be determined by NMR using
\100 lg quantities of protein samples with micro NMR
probes [3]. These technologies are enhanced by the recent
introduction of Bruker micro cryo NMR probes, like the
one used in this work. Thus, there is a natural synergy
between WGCF protein expression and micro cryo NMR
probe technologies. In addition, WGCF systems can
accommodate selective labeling strategies for single pro-
teins—something that cannot easily be achieved in whole
cell systems. This includes incorporation of SAIL (‘‘Stereo
Array Isotope Labeling’’) amino acids, which are valuable
for NMR studies of larger proteins [10].
In this work, modiﬁcations were made to pTSHQn, a
TNT
 SP6 High-Yield WGCF expression system vector, to
enable parallel implementations of WGCF and in-cell pET
vector cloning strategies. Using this system we have
assessed expression and solubility for 59 NESG human
protein targets, *60% of which could not be expressed in a
soluble form in our E. coli intracellular pET system. Forty
of these human proteins were produced at levels sufﬁcient
to be considered for NMR studies ([100 lg) using the
TNT WGCF system; 25 of these could not be produced in
soluble form using the cell-based E. coli system. Modiﬁ-
cations were made in the TNT WGCF system by depletion
of amino-acids from the lysate, to allow incorporation of
labeled amino acids. Human ubiquitin and NESG human
protein target HR3597B were
15N-,
13C-enriched, and
puriﬁed using a modiﬁed TNT WGCF medium. Each
reaction produced *30–60 lg of labeled protein per mL of
WGCF dialysis reaction volume. In this work, TNT WGCF
expression and micro cryo NMR probe technology were
combined for the ﬁrst time, and promising HSQC results
Table 2 Labeling efﬁciency of
ubiqutin produced using the
modiﬁed Promega TNT WGCF
system with two different
concentrations of labeled amino
acids in the reaction mixture
Peptide sequence Position 0.1 mM labeled aa’s (%) 1 mM labeled aa’s (%)
EGIPPDQQR 44–52 68.9 93.7
ESTLHLVLR 74–82 73.4 96.4
IQDKEGIPPDQQR 40–52 66.6 94.0
TITLEVEPSDTIENVK 22–37 77.2 93.2
Fig. 4 Micro cryo NMR probe
15N-
1H 2D HSQC spectra at
25 Co fA human ubiquitin and






Spectra were obtained using a
600 MHz 1.7 mm Bruker micro
cryo NMR probe using 100–
200 lg of protein sample each
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123were obtained for the two test proteins, suggesting that the
structural analysis by NMR of such WGCF produced
proteins will become routine in the not-so-distant future.
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